Vigorimeter grip strength in CIDP: A responsive tool that rapidly measures the effect of IVIG - the ICE study

European Journal of Neurology

Volumn 20, Issue 5, 2013, Pages 748-755

  Vanhoutte, E K ^a   Latov, N ^b   Deng, C ^c   Hanna, K ^c   Hughes, R A C ^d   Bril, V ^e   Dalakas, M C ^f   Donofrio, P ^g   van Doorn, P A ^h   Hartung, H P ⁱ   Merkies, I S J ^a,j  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Grifols   (United States)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^e UNIVERSITY OF TORONTO   (Canada)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g VANDERBILT UNIVERSITY   (United States)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j Department of Orthopaedic Surgery   (Netherlands)

more..

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Disability; Grip strength; Immune globulin; Inflammatory neuropathy

Indexed keywords

HUMAN IMMUNOGLOBULIN; PLACEBO;

ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; GRIP STRENGTH; HUMAN; INFLAMMATORY NEUROPATHY CAUSE AND TREATMENT DISABILITY SCALE; MAJOR CLINICAL STUDY; MEDICAL DEVICE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; VIGORIMETER;

DISABILITY EVALUATION; DOUBLE-BLIND METHOD; HAND STRENGTH; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 84876328802     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03851.x     Document Type: Article

References (17)

1. Merkies IS, Lauria G. 131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Naarden, The Netherlands. Neuromuscul Disord 2006; 16: 149-156.
2. Hughes R, Bensa S, Willison H, et al., the Inflammatory Neuropathy Cause and Treatment Group. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001; 50: 195-201.
3. Hughes R, Donofrio P, Bril V, et al., on behalf of the ICE Study Group. Intravenous immune globulin (10% caprylate/chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE Study): a randomised placebo-controlled trial. Lancet Neurol 2008; 7: 136-144.
4. Fünfgeld EW. Vigorimeter: Zur Kraftmessung der Hand und zur Simulationsprüfung. Dtsch Med Wochenschr 1966; 49: 2214-2216.
5. Merkies ISJ, Schmitz PIM, Samijn JPA, et al. Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies. Muscle Nerve 2000; 23: 1393-1401.
6. American Society of Hand Therapists. Clinical Assessment Recommendations, 2nd edn. Chicago, IL: 1992. p. 43.
7. ® Health Survey: Manual and Interpretation Guide. Lincoln, RI: QualityMetric Incorporated, 2000.
8. Sloan J, Symonds T, Vargas-Chanes D, et al. Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials. Drug Inf J 2003; 37: 23-31.
9. Merkies IS, van Nes SI, Hanna K, et al. Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance. J Neurol Neurosurg Psychiatry 2010; 81: 1194-1199.
10. Liang MH. Evaluating measurement responsiveness. J Rheumatol 1995; 22: 1191-1192.
11. Latov N, Deng C, Dalakas MC, et al. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol 2010; 67: 802-807.
12. Örndahl G, Sellden U, Hallin S, et al. Myotonic dystrophy treated with selenium and vitamin E. Acta Med Scand 1986; 219: 407-414.
13. Rhind VM, Bird HA, Wright V. A comparison of clinical assessments of disease activity in rheumatoid arthritis. Ann Rheum Dis 1980; 39: 135-137.
14. Dyck PJ. Dynametric assessment in CIDP. Muscle Nerve 2009; 39: 421-422.
15. Harbo T, Andersen H, Jakobsen J. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2009; 39: 439-447.
16. Merkies IS, Hughes RA, Donofrio P, et al., ICE Study Group. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. J Peripher Nerv Syst 2010; 15: 208-215.
17. Sunderland A, Tinson D, Bradley L, et al. Arm function after stroke. An evaluation of grip strength as a measure of recovery and a prognostic indicator. J Neurol Neurosurg Psychiatry 1989; 52: 1267-1272.